# David A. Scheinberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-a-scheinberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,522 |
| Field | Monoclonal and Polyclonal Antibodies Research |
| h-index | 81 |
| i10-index | 248 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5006680533 |
| ORCID iD | https://orcid.org/0000-0002-4160-923X |
| Works | 515 |

## Researcher papers

- [Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia](https://scholariq.org/papers/phase-iii-randomized-multicenter-study-of-a-humanized-anti-cd33-monoclonal/)
- [Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma](https://scholariq.org/papers/selective-inhibition-of-hdac3-targets-synthetic-vulnerabilities-and-activates/)

## Researcher topics

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.